Register      Login
New South Wales Public Health Bulletin New South Wales Public Health Bulletin Society
Supporting public health practice in New South Wales
RESEARCH ARTICLE

Ensuring the policy relevance of population health research: experiences from the Drug Policy Modelling Program

Alison Ritter
+ Author Affiliations
- Author Affiliations

National Drug and Alcohol Research Centre, The University of New South Wales
Email: alison.ritter@unsw.edu.au

NSW Public Health Bulletin 22(2) 19-22 https://doi.org/10.1071/NB10062
Published: 19 April 2011

Abstract

Illicit drugs are an important public health concern. A unique approach to tackling this problem is represented in the work of the Drug Policy Modelling Program which aims to improve evidence-informed policy by reducing the gap between research and policy. There are three elements to the Drug Policy Modelling Program: generating new knowledge; translating evidence into information of relevance for decision makers; and studying policy processes. Key aspects include the use of computer modelling as a translational tool and the focus on understanding policy processes such as the role of media and politics, important in contextualising the research-policy nexus. Other features of the Drug Policy Modelling Program approach include engagement of diverse disciplines, and government researcher partnerships.


References

[1]  Collins DJ, Lapsley HM. The cost of tobacco, alcohol and illicit drug abuse to Australian society in 2004/05. National Drug Strategy Monograph Series No. 64. Commonwealth of Australia; 2008.

[2]  Hall W. The contribution of research to Australian policy responses to heroin dependence 1990–2001: a personal retrospection. Addiction 2004; 99 560–9.
The contribution of research to Australian policy responses to heroin dependence 1990–2001: a personal retrospection.Crossref | GoogleScholarGoogle Scholar | 15078230PubMed |

[3]  Fitzgerald J, Sewards T. Evidence-Based Practice in the Australian Drug Policy Community. In: Lin V, Gibson B, editors. Evidence-based health policy: problems and possibilities. Melbourne: Oxford University Press; 2003.

[4]  Agar M. How the drug field turned my beard grey. Int J Drug Policy 2002; 13 249–59.
How the drug field turned my beard grey.Crossref | GoogleScholarGoogle Scholar |

[5]  Ritter A, Bammer G, Hamilton M, Mazerolle L. DPMP Team. Effective drug policy: a new approach demonstrated in the Drug Policy Modelling Program. Drug Alcohol Rev 2007; 26 265–71.
DPMP Team. Effective drug policy: a new approach demonstrated in the Drug Policy Modelling Program.Crossref | GoogleScholarGoogle Scholar | 17454015PubMed |

[6]  Lin V, Gibson B, editors. Evidence-based health policy: problems and possibilities. Melbourne: Oxford University Press; 2003.

[7]  Edwards M. Social science research and public policy: narrowing the divide. Aust J Public Administration 2005; 64 68–74.
Social science research and public policy: narrowing the divide.Crossref | GoogleScholarGoogle Scholar |

[8]  Balas EA, Boren SA. Managing clinical knowledge for health care improvement. In: Bemmel J, McCray AT, editors. Yearbook of Medical Informatics 2000: Patient-Centered Systems. Stuttgart: Schattauer; 2000. pp. 65–70.

[9]  Sanson-Fisher RW, Campbell EM, Htun AT, Bailey LJ, Millar CJ. We are what we do: research outputs of public health. Am J Prev Med 2008; 35 380–5.
We are what we do: research outputs of public health.Crossref | GoogleScholarGoogle Scholar | 18687567PubMed |

[10]  Mazerolle L, Soole D, Rombouts S. Monograph No. 05. Drug law enforcement: The evidence. DPMP Monograph Series. Fitzroy: Turning Point Alcohol and Drug Centre; 2005.

[11]  Mazerolle L, Soole D, Rombouts S. Street-level drug law enforcement: a meta-analytic review. J Exp Criminol 2006; 2 409–35.
Street-level drug law enforcement: a meta-analytic review.Crossref | GoogleScholarGoogle Scholar |

[12]  Mazerolle L, Soole D, Rombouts S. Drug law enforcement: a review of the evaluation literature. Police Q 2007; 10 115–53.
Drug law enforcement: a review of the evaluation literature.Crossref | GoogleScholarGoogle Scholar |

[13]  Drew JM. Police responses to the methamphetamine problem: an analysis of the organizational and regulatory context. Police Q, in press.

[14]  Brownson RC, Royer C, Ewing R, McBride TD. Researchers and policymakers: travelers in parallel universes. Am J Prev Med 2006; 30 164–72.
Researchers and policymakers: travelers in parallel universes.Crossref | GoogleScholarGoogle Scholar | 16459216PubMed |

[15]  Crosswaite C, Curtice L. Disseminating research results – the challenge of bridging the gap between health research and health action. Health Promot Int 1994; 9 289–96.
Disseminating research results – the challenge of bridging the gap between health research and health action.Crossref | GoogleScholarGoogle Scholar |

[16]  Hanney SR, Gonzalez-Block MA, Buxton MJ, Kogan M. The utilisation of health research in policy-making: concepts, examples and methods of assessment. Health Res Policy Syst 2003; 1 2
The utilisation of health research in policy-making: concepts, examples and methods of assessment.Crossref | GoogleScholarGoogle Scholar | 12646071PubMed |

[17]  Stone D, Maxwell S, Keating M. Bridging research and policy. UK Department for International Development, Radcliffe House, Warwick University: Warwick, UK; 2001. p. 50.

[18]  Weiss CH, editor. Using social research in public policy making. Lexington, MA: Lexington Books; 1977.

[19]  Meadows DH, Robinson JM. The electronic oracle: computer models and social decisions. Syst Dyn Rev 2002; 18 271–308.
The electronic oracle: computer models and social decisions.Crossref | GoogleScholarGoogle Scholar |

[20]  Zeiler I, Langlands T, Murray JM, Ritter A. Optimal targeting of Hepatitis C virus treatment among injecting drug users to those not enrolled in methadone maintenance programs. Drug Alcohol Depend 2010; 110 228–33.
Optimal targeting of Hepatitis C virus treatment among injecting drug users to those not enrolled in methadone maintenance programs.Crossref | GoogleScholarGoogle Scholar | 20430537PubMed |

[21]  Chalmers J, Ritter A, Heffernan M, McDonnell G. Modelling pharmacotherapy maintenance in Australia: exploring affordability, availability, accessibility and quality using system dynamics. ANCD Research Paper #19. Canberra: Australian National Council on Drugs; 2009.

[22]  Dray A, Mazerolle L, Perez P, Ritter A. Drug law enforcement in an agent-based model: simulating the disruption to street-level drug markets. In: Liu L, Eck J, editors. Artificial crime analysis systems: using computer simulations and geographic information systems. Hershey, PA: IGI Global; 2008. pp. 352–71.

[23]  Dray A, Mazerolle L, Perez P, Ritter A. Policing Australia's ‘heroin drought': using an agent-based model to simulate alternative outcomes. J Exp Criminol 2008; 4 267–87.
Policing Australia's ‘heroin drought': using an agent-based model to simulate alternative outcomes.Crossref | GoogleScholarGoogle Scholar |

[24]  Perez P, Dray A, Ritter A, Dietze P, Moore T, Mazerolle L. SimDrug: exploring the complexity of illicit drug markets. In: Perez P, Batten D, editors. Complex science for a complex world – Exploring human ecosystems with agents. Canberra: ANU E press; 2006. pp. 193–224.

[25]  Weiss CH, Murphy-Graham E, Birkeland S. An alternate route to policy influence: how evaluations affect D.A.R.E. Am J Eval 2005; 26 12–30.
An alternate route to policy influence: how evaluations affect D.A.R.E.Crossref | GoogleScholarGoogle Scholar |

[26]  Kingdon T. Agendas, alternatives, and public policy. 2nd ed. New York: Longman; 2003.

[27]  Sabatier PA, editor. Theories of policy processes. Colorado: Westview Press; 2007.

[28]  Ritter A, Bammer G. Models of policy making and their relevance for drug research. Drug Alcohol Rev 2010; 29 352–7.
Models of policy making and their relevance for drug research.Crossref | GoogleScholarGoogle Scholar | 20636649PubMed |

[29]  Matthew-Simmons F, Love S, Ritter A. Monograph 17: A review of Australian public opinion surveys on illicit drugs. DPMP Monograph Series. Sydney: National Drug and Alcohol Research Centre; 2008.

[30]  Weiss CH. The many meanings of research utilization. Public Adm Rev 1979; 39 426–31.
The many meanings of research utilization.Crossref | GoogleScholarGoogle Scholar |

[31]  Ritter A. How do drug policy makers access research evidence? Int J Drug Policy 2009; 20 70–5.
How do drug policy makers access research evidence?Crossref | GoogleScholarGoogle Scholar | 18226519PubMed |

[32]  Nathan SA, Develin E, Grove N, Zwi AB. An Australian childhood obesity summit: the role of data and evidence in ‘public’ policy making. Aust New Zealand Health Policy 2005; 2 17
An Australian childhood obesity summit: the role of data and evidence in ‘public’ policy making.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD2MvntFajuw%3D%3D&md5=c8c63a01ba977d650ee10fb34af9b488CAS | 16029512PubMed |

[33]  Van Beek I. In the eye of the needle: diary of a medically supervised injecting centre. Crows Nest: Allen & Unwin; 2004.